DCF Advisers, LLC - Q4 2019 holdings

$158 Million is the total value of DCF Advisers, LLC's 69 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was - .

 Value Shares↓ Weighting
ITCI NewINTRA CELLULAR THERAPIES INC$16,060,000468,073
+100.0%
10.17%
GLD NewSPDR GOLD TRUST$9,289,00065,000
+100.0%
5.88%
MU NewMICRON TECHNOLOGY INC$8,067,000150,000
+100.0%
5.11%
GOOG NewALPHABET INCcap stk cl c$7,688,0005,750
+100.0%
4.87%
C NewCITIGROUP INC$5,992,00075,000
+100.0%
3.79%
T NewAT&T INC$5,862,000150,000
+100.0%
3.71%
GLD NewSPDR GOLD TRUSTcall$5,716,00040,000
+100.0%
3.62%
BAC NewBANK AMER CORP$5,635,000160,000
+100.0%
3.57%
ABBV NewABBVIE INC$5,188,00058,600
+100.0%
3.28%
REGN NewREGENERON PHARMACEUTICALS$5,031,00013,400
+100.0%
3.19%
ALNY NewALNYLAM PHARMACEUTICALS INC$4,607,00040,000
+100.0%
2.92%
VZ NewVERIZON COMMUNICATIONS INCcall$4,298,00070,000
+100.0%
2.72%
INCY NewINCYTE CORP$3,929,00045,000
+100.0%
2.49%
AMD NewADVANCED MICRO DEVICES INC$3,898,00085,000
+100.0%
2.47%
BMY NewBRISTOL MYERS SQUIBB CO$3,819,00059,500
+100.0%
2.42%
ARGX NewARGENX SEsponsored adr$3,531,00022,000
+100.0%
2.24%
ORCL NewORACLE CORP$3,444,00065,000
+100.0%
2.18%
IWM NewISHARES TRcall$3,313,00020,000
+100.0%
2.10%
AMRN NewAMARIN CORP PLCspons adr new$3,216,000150,000
+100.0%
2.04%
AMGN NewAMGEN INC$3,013,00012,500
+100.0%
1.91%
IAU NewISHARES GOLD TRUSTishares$2,900,000200,000
+100.0%
1.84%
AOD NewABERDEEN TOTAL DYNAMIC DIVD$2,519,000281,417
+100.0%
1.60%
ECA NewENCANA CORP$2,310,000492,500
+100.0%
1.46%
HD NewHOME DEPOT INC$2,184,00010,000
+100.0%
1.38%
SLB NewSCHLUMBERGER LTDcall$2,010,00050,000
+100.0%
1.27%
IBM NewINTERNATIONAL BUSINESS MACHScall$2,011,00015,000
+100.0%
1.27%
SGEN NewSEATTLE GENETICS INC$1,942,00017,000
+100.0%
1.23%
XNCR NewXENCOR INC$1,940,00056,425
+100.0%
1.23%
SPY NewSPDR S&P 500 ETF TRput$1,609,0005,000
+100.0%
1.02%
XLNX NewXILINX INC$1,540,00015,750
+100.0%
0.98%
FMS NewFRESENIUS MED CARE AG&CO KGAsponsored adr$1,381,00037,500
+100.0%
0.88%
BDX NewBECTON DICKINSON & COcall$1,360,0005,000
+100.0%
0.86%
TXN NewTEXAS INSTRS INCcall$1,283,00010,000
+100.0%
0.81%
M NewMACYS INC$1,275,00075,000
+100.0%
0.81%
WBA NewWALGREENS BOOTS ALLIANCE INCcall$1,179,00020,000
+100.0%
0.75%
IEMG NewISHARES INCcall$1,129,00021,000
+100.0%
0.72%
NLOK NewNORTONLIFELOCK INC$1,021,00040,000
+100.0%
0.65%
SQ NewSQUARE INCcall$938,00015,000
+100.0%
0.59%
NKTR NewNEKTAR THERAPEUTICS$928,00043,000
+100.0%
0.59%
VZ NewVERIZON COMMUNICATIONS INC$921,00015,000
+100.0%
0.58%
ESPR NewESPERION THERAPEUTICS INC NE$894,00015,000
+100.0%
0.57%
QCOM NewQUALCOMM INC$882,00010,000
+100.0%
0.56%
FGEN NewFIBROGEN INC$751,00017,500
+100.0%
0.48%
AAPL NewAPPLE INC$734,0002,500
+100.0%
0.46%
GDX NewVANECK VECTORS ETF TRUSTcall$732,00025,000
+100.0%
0.46%
CSCO NewCISCO SYS INCcall$719,00015,000
+100.0%
0.46%
BIF NewBOULDER GROWTH & INCOME FD I$693,00058,783
+100.0%
0.44%
MTNB NewMATINAS BIOPHARMA HLDGS INC$622,000274,009
+100.0%
0.39%
INTC NewINTEL CORP$599,00010,000
+100.0%
0.38%
BOX NewBOX INCcl a$587,00035,000
+100.0%
0.37%
NOK NewNOKIA CORPsponsored adr$557,000150,000
+100.0%
0.35%
HD NewHOME DEPOT INCcall$546,0002,500
+100.0%
0.35%
M NewMACYS INCcall$510,00030,000
+100.0%
0.32%
AYX NewALTERYX INC$500,0005,000
+100.0%
0.32%
AERI NewAERIE PHARMACEUTICALS INC$495,00020,500
+100.0%
0.31%
APTV NewAPTIV PLC$475,0005,000
+100.0%
0.30%
SGMO NewSANGAMO THERAPEUTICS INC$451,00053,900
+100.0%
0.29%
NXPI NewNXP SEMICONDUCTORS N V$445,0003,500
+100.0%
0.28%
NOK NewNOKIA CORPcall$371,000100,000
+100.0%
0.24%
KIRK NewKIRKLANDS INC$331,000267,119
+100.0%
0.21%
ADMS NewADAMAS PHARMACEUTICALS INC$318,00083,875
+100.0%
0.20%
SQ NewSQUARE INCcl a$313,0005,000
+100.0%
0.20%
APTX NewAPTINYX INC$312,00091,300
+100.0%
0.20%
ERIC NewERICSSONadr b sek 10$307,00035,000
+100.0%
0.19%
ET NewENERGY TRANSFER LP$257,00020,000
+100.0%
0.16%
BOX NewBOX INCcall$252,00015,000
+100.0%
0.16%
SGMO NewSANGAMO THERAPEUTICS INCcall$124,00014,800
+100.0%
0.08%
IDRA NewIDERA PHARMACEUTICALS INC$93,00051,051
+100.0%
0.06%
BGY NewBLACKROCK ENHANCED INTL DIV$71,00012,000
+100.0%
0.04%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-02-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
INTRA-CELLULAR THERAPIES INC16Q3 202310.2%
MICRON TECHNOLOGY INC16Q3 20236.7%
ALPHABET INC16Q3 20235.8%
ABBVIE INC16Q3 20237.9%
REGENERON PHARMACEUTICALS16Q3 20235.5%
ARGENX SE16Q3 20236.4%
SPDR GOLD TRUST16Q3 20236.6%
XENCOR INC16Q3 20234.1%
BK OF AMERICA CORP16Q3 20235.4%
ORACLE CORP16Q3 20233.2%

View DCF Advisers, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-13
13F-HR2023-08-09
13F-HR2023-05-15
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-11
13F-HR2022-05-13
13F-HR2022-02-10
13F-HR2021-11-15

View DCF Advisers, LLC's complete filings history.

Compare quarters

Export DCF Advisers, LLC's holdings